40314-71-4 Usage
Uses
Used in Agricultural Industry:
4,6-Dichloropicolinonitrile is used as a herbicidal agent for controlling the growth of broadleaf and grassy weeds. It functions as a systemic herbicide, being absorbed by the roots and foliage of plants, thereby inhibiting their growth and serving as an effective tool in weed management.
Used in Chemical Synthesis:
4,6-Dichloropicolinonitrile is utilized as an intermediate in the synthesis of other chemicals and pharmaceuticals. Its unique chemical structure makes it a valuable component in the creation of various compounds, contributing to the development of new products in the chemical and pharmaceutical industries.
Safety Precautions:
Given its potential toxicity and the risk of causing skin and eye irritation upon contact, 4,6-Dichloropicolinonitrile requires careful handling. It is crucial to implement proper safety measures to prevent ingestion or inhalation, which could lead to health hazards. The use of personal protective equipment and adherence to safety protocols are essential when working with this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 40314-71-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,3,1 and 4 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 40314-71:
(7*4)+(6*0)+(5*3)+(4*1)+(3*4)+(2*7)+(1*1)=74
74 % 10 = 4
So 40314-71-4 is a valid CAS Registry Number.
40314-71-4Relevant academic research and scientific papers
IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS HISTONE DEMETHYLASE INHIBITORS
-
, (2018/01/15)
This disclosure relates, inter alia, to compounds that inhibit histone demethylase activity. In particular, the disclosure relates to compounds that inhibit histone lysine demethylase KDM5B, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions disclosed herein.
Discovery of anilinopyrimidines as dual inhibitors of c-Met and VEGFR-2: Synthesis, SAR, and cellular activity
Zhan, Zhengsheng,Ai, Jing,Liu, Qiufeng,Ji, Yinchun,Chen, Tiantian,Xu, Yechun,Geng, Meiyu,Duan, Wenhu
supporting information, p. 673 - 678 (2014/07/07)
Both c-Met and VEGFR-2 are important targets for cancer therapies. Here we report a series of potent dual c-Met and VEGFR-2 inhibitors bearing an anilinopyrimidine scaffold. Two novel synthetic protocols were employed for rapid analoguing of the designed
